Showing results (2401-2410 of 2,709) with videos related to

Sort By:
Pageof 271
European Journal of Cancer (Oxford, England : 1990)|May 4, 2023
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164Dung T Le, Luis A Diaz, Tae Won Kim, et al.
Science Translational Medicine|August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejectionAnna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
Forensic Science International. Genetics|February 24, 2026
Comparative evaluation of SNP sequencing workflows for identification of the missing in VietnamBethany K Forsythe, Bas van Haperen, Lisa Vangeel, et al.
International Journal of Cardiology|February 23, 2016
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trialD Guijarro, M Lebrin, O Lairez, et al.
Future Oncology (London, England)|October 6, 2025
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)Maeve A Hennessy, Constantine Gatsonis, Heather Jacene, et al.
Frontiers in Oncology|September 5, 2022
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cellsAram S Modrek, Eskil Eskilsson, Ravesanker Ezhilarasan, et al.
NPJ Precision Oncology|February 5, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunityEmily K Kleczko, Trista K Hinz, Teresa T Nguyen, et al.
The Lancet. Oncology|April 15, 2022
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 studyLuis A Diaz, Kai-Keen Shiu, Tae-Won Kim, et al.
American Journal of Clinical Oncology|December 20, 2013
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic CancerFarzana Faisal, Hua-Ling Tsai, Amanda Blackford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutationsNhat T T Le, Lydia Chang, Irina Kovlyagina, et al.
Pageof 271